| Titre : | Urinary isoflavonoids and risk of coronary heart disease. (2012) |
| Auteurs : | . XIANGLAN ZHANG ; FRANKE (Adrian-A) : USA. University of Hawaii Cancer Center. Honolulu. HI. ; Yu-Tang GAO ; . GONG YANG ; . HONGLAN LI ; JI (Bu-Tian) : USA. Division of Cancer Epidemiology and Genetics. Nci. Nih. Bethesda. MD. ; . QIUYIN CAI ; Xiao-Ou SHU ; . WEI ZHENG ; Yong-Bing XIANG |
| Type de document : | Article |
| Dans : | International journal of epidemiology (vol. 41, n° 5, 2012) |
| Pagination : | 1367-1375 |
| Langues: | Anglais |
| Mots-clés : | Cardiopathie coronaire ; Facteur risque ; Risque ; Aliment |
| Résumé : | [BDSP. Notice produite par INIST-CNRS jntAlR0x. Diffusion soumise à autorisation]. Background Whether soy food consumption may protect against coronary heart disease (CHD) remains controversial. No previous study has used biomarkers of soy intake in assessing the relationship between soy consumption and CHD. Biomarkers that reflect both intake and metabolism may be more informative than self-reports of dietary intake. Methods We examined associations of urinary isoflavonoids, a biomarker of soy or soy isoflavone intake, with risk of CHD in a case-control study nested within two prospective cohort studies of Chinese adults in Shanghai. Cases were defined as subjects with no history of CHD at baseline who developed incident CHD during follow-up. Control subjects were randomly selected from those who remained free of CHD and matched to cases by sex, age, date and time of sample collection and antibiotic use. Baseline urinary isoflavonoids (daidzein, genistein, glycitein, equol, O-desmethylangolensin, dihydrodaidzein and dihydrogenistein) were compared between cases (n=377) and control subjects (n=753). Conditional logistic regression was used to evaluate the associations. Results Total urinary isoflavonoids were not associated with CHD in either women or men. However, urinary equol excretion showed a significant inverse association with CHD in women. The adjusted odds ratios (95% confidence intervals) for CHD across increasing quartiles of equol levels in women were 1 (reference), 0.61 (0.32,1.15), 0.51 (0.26,0.98) and 0.46 (0.24,0.89) (P=0.02 for trend). Conclusions Our study suggests for the first time that equol, a bioactive metabolite of soy isoflavone daidzein, may be inversely associated with risk of CHD in women. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact